Building in technology or healthcare and wondering how to get funding from Polaris Partners? Founded in 1996 and headquartered in Boston, this is one of the veteran US venture firms investing across technology and healthcare — from seed and early stage to high-growth middle-market businesses. Polaris Partners funding typically comes as a lead or co-lead position with an active, long-term role, and the firm describes itself as managing more than $3.5 billion in capital. For founders who want an investor built for the long haul, three decades of continuity is the pitch.

Thesis and sweet spot

Polaris Partners invests in exceptional technology and healthcare companies across all stages of their lifecycles — seed and early-stage startups through high-growth middle-market businesses — taking minority and majority positions, typically as lead or co-lead investor. Offices in Boston, San Francisco and Dublin give it a transatlantic footprint, unusual for a firm of its vintage.

The sweet spot is founders who want an involved, long-duration partner: Polaris takes an active role and stays engaged across cycles. Its dual technology-healthcare mandate means it can follow companies as they evolve across sectors — a flexibility single-thesis firms cannot match.

Cheque size and fund

Polaris describes itself as managing more than $3.5B in capital (its long-standing firm boilerplate). A 2019-era report put assets past $4.3B plus a $175M growth vehicle following Fund VIII's final close, and Fund IX targeted $400M per an SEC filing. These figures are dated and no current AUM is confirmed, so they are presented as historical markers. The firm does not publicly disclose a cheque-size range.

Notable portfolio

The portfolio spans both mandates: Editas Medicine (the genome-editing company co-created by Polaris alongside Third Rock and Flagship), August Biosciences, Seismic Therapeutic, Dewpoint Therapeutics, BeMe Health and ByHeart on the healthcare side, and LogMeIn and Drizly among its technology outcomes. The Editas co-creation is the signature example of the firm's company-building capability.

Partners

Dave Barrett serves as senior advisory partner in Boston focused on healthcare technology, and managed Polaris Funds VI through IX. The firm's public team pages are thin on individually verified partner names beyond Barrett, so this profile does not attribute additional partners.

Programs, credits and perks

Polaris does not currently run a public accelerator or credits programme. Historically, the firm operated Dogpatch Labs, an entrepreneur co-working and mentorship space in the 2010 era, but its current status is not confirmed on the firm's site. The value-add is the partnership itself: active, long-term involvement from a team that has invested through multiple cycles.

How to apply for funding

Polaris Partners does not publish a pitch email or application form. Founders typically reach the team through warm introductions in the Boston, Bay Area or Dublin technology and healthcare networks. A pitch that explains why a multi-decade, cross-stage partner fits the company's journey will stand out.

Why it matters for founders

If you want an investor that leads, stays active and invests across stages, Polaris Partners' three-decade technology-healthcare record is the credential. Come with a company built for the long term — that is the firm's language.